Deka Research and Development
Explore this company’s associated devices, FDA decisions and regulatory history.

Deka Research and Development
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Deka Research and Development. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 3, 2026 to Jun 17, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code FPA appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 340 Commercial St., Manchester, NH, 03101, US. Recorded on K261672, decision dated Jun 17, 2026.
Device categories in this collection
Alternate Controller Enabled Insulin Infusion Pump; Set, Administration, Intravascular.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Deka Research and Development | 510(k) clearance | Jun 17, 2026 | FDA | |
iiSure Infusion SetK261530 | Deka Research and Development | 510(k) clearance | Jun 3, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.

